Compare Injective (INJ) vs Orchid (OXT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Orchid — how do they compare? Injective trades at Rp75,554 (market cap Rp7,49T, Rp831,89M 24h volume), while Orchid trades at Rp164.34 (market cap Rp190,2M, Rp47,84M 24h volume). The key difference: Injective is far larger — about 39379.6× Orchid's market cap, and Injective's circulating supply is 100M INJ versus 997,2M OXT for Orchid. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Orchid for 44 Days on average.
| INJ | OXT | |
|---|---|---|
Market Cap | Rp7,49T | Rp190,2M |
Volume (24h) | Rp831,89M | Rp47,84M |
Circulating Supply | 100M INJ | 997,2M OXT |
Typical Hold Time | 37 Days | 44 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Orchid (OXT) exhibits a very low market capitalization of Rp190.2M, indicating a micro-cap token with limited market presence. The average hold time of 44 days suggests some short-term accumulation, but the absence of a current price and recent price data limits technical trend analysis. No major protocol updates or significant ecosystem developments have been reported recently, pointing to a period of low network activity.
Overall outlook is highly speculative due to the token's small size and low liquidity. The key opportunity lies in potential future protocol adoption, but major risks include extreme volatility, low trading volume, and the inherent fragility of micro-cap assets in the crypto market. Investors should be aware of the high probability of significant price swings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Orchid
Orchid describes itself as the world’s first incentivized, peer-to-peer privacy network. Its aim is to overcome internet freedom limitations by using cryptocurrency payments to allow anyone to purchase bandwidth from any participating provider. This is done using so-called probabilistic nanopayments, which occur using OXT, an ERC-20 standard token on Ethereum.
Read more on OXT →
